Past success is an excellent of predictor of future success in commercialization. Our achievements demonstrate that BLG has the skills, knowledge and experience to help you.
Read highlights below for a selection of featured license agreements and licensing relationships with established industry partners, investor groups, and startup companies, as well as collaboration with our peer academic institutions to commercialize jointly-developed inventions.
Developments with Longstanding Licensing Relationships
Takeda Pharmaceuticals
A Decade of Academia-Industry Joint Efforts in Developing a Human Norovirus Vaccine Candidate.
Opexa Therapeutics, Inc.
Opexa Therapeutics Reaches Clinical Development Milestone Event in Development of a Personalized Therapy for Secondary Progressive Multiple Sclerosis.
TyRx, Inc.
TyRx, Inc., Expands Market and Introduces Bioresorbable AIGISRx R Antibacterial Envelope.
Exclusive License Agreements
Celgene Corporation
Celgene, bluebird bio, and the Center for Cell and Gene Therapy Combine Strengths and Resources to Develop T-cell Based Therapies for Cancer
Vax-Immune, LLC
Vax-Immune Acquires Exclusive Worldwide Rights to Baylor College of Medicine’s Ureaplasma Technology.
Shenzhen Tiande Investment Co., LTD.
Shenzhen Tiande Investment Co., LTD., Licenses Esophageal Cancer Biomarkers.
Acer Therapeutics, Inc.
Acer Therapeutics Develops the First Pharmaceutical Therapy for Maple Syrup Urine Disease (MSUD)
StemMed, Ltd.
StemMed, Ltd., Licenses STAT3 Inhibitors - Local Company Developing Novel Compounds Against a Key Cancer Target
Non-Exclusive Licensed Technologies
pINDUCER Lentiviral Vectors
pINDUCER Lentiviral Vectors for Inducible RNAi in vitro and in vivo.
The TRAMP Mouse Model and Cell Lines
The TRAMP Mouse Model and Cell Lines - A Research Tool’s Popularity Marches On
Master Agreements
American Type Culture Collection (ATCC)
ATCC Master Agreement - BCM Poised to Benefit from Commercial Use of Deposited Materials.
The Estes lab and ImmuCell Success Story
After more than 20 years of research, discoveries from the lab of Dr. Mary Estes reached the point where they evolved into practical applications that improve the quality of life.
BLG Annual Report 2016
View the FY'16 annual report pdf for information on the year in review, agreement highlights, profiles in innovation, and more.
